scorecardresearch
Thursday, August 7, 2025
TopicObesity

Topic: Obesity

Tackling mental health problems and obesity key to India’s growth — Economic Survey

Survey emphasises a balanced and diverse diet to deal with the burgeoning obesity problem. It also recognises mental health as a principal factor in individual & national development.

Blockbuster diabetes & obesity drug gets nod for India launch but may be available only next year

Tirzepatide is a type 2 diabetes and obesity drug sold by US firm Eli Lilly under the brand names Mounjaro and Zepbound. It may take around 6 months for it to be launched in India.

Govt panel urges regulator to approve import of American drug for diabetes, obesity

Lilly's Mounjaro is a popular choice for weight loss. Mounjaro is expected to launch in India in India in 2025.

82.5 mn Indians were ‘obese’ in 2022, shows Lancet study. Doctors, nutritionists say ‘tip of iceberg’

Study, conducted by NCD Risk Factor Collaboration & WHO, shows that nearly 880 million adults globally living with obesity in 2022 — 4.5 times higher than the number recorded in 1990.

Diabetes drug semaglutide offers hope beyond obesity management — kidney, heart & liver health

Study by Australian & Canadian scientists, published in Kidney International, finds that drug may be effective at reducing inflammation — lowering risk of heart & kidney disease.

Social isolation and loneliness are as fatal as smoking and obesity

Social isolation experienced in childhood can foreshadow health issues decades later.

Tirzepatide, another diabetes drug cleared for weight loss in US, yet to get regulator nod in India

In clinical trials, tirzepatide by Eli Lilly has shown to reduce body weight by up to 22.5 percent, on average, after about 72 weeks, according to the company.

Desperate Indians want Ozempic on prescription. Huge shift from traditional drugs, say doctors

Given the hype, semaglutide is gaining traction across India with the requests pouring in – more so in private, luxury clinics.

In a 1st, US heart association defines condition linking heart, kidney disease, diabetes & obesity

Advisory by American Heart Association classifies cardiovascular-kidney-metabolic (CKM) syndrome into 4 stages, with therapeutic & screening strategies suggested for each.

Obesity is similar to cancer. But it doesn’t get society-wide recognition as a disease

There is also evidence that obesity is accompanied by brain inflammation and increased risk of mental health conditions such as major depressive disorder and anxiety.

On Camera

AI integration for military is risky business. Combat monopoly must remain with soldiers

The Army has plans for a technology thrust in the near term, including the use of AI to support decision-making. While well-intentioned, this may have unintended consequences.

Web of spoof sites, scam call centres. Crypto theft racket modus operandi in focus amid ED crackdown

As part of the crypto theft racket, businessman Chirag Tomar and his aides targeted 542 victims and managed to steal a total of Rs 19.9 million.

Pakistan army chief Asim Munir to attend CENTCOM chief’s farewell, second visit to US in two months

Munir was earlier in America in June when he had a two-hour luncheon meeting with the US president at the White House.

Pakistan, Dhaka have played Washington well. Back home, Modi ecosystem has an inner conflict

To protect ourselves from Trumpian diplomacy, first we must introspect the bipolarity within our establishment discourse.